319 related articles for article (PubMed ID: 16217983)
1. Insulin resistance in polycystic ovarian disease.
Bhatia V
South Med J; 2005 Sep; 98(9):903-10; quiz 911-2, 923. PubMed ID: 16217983
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
Dhindsa G; Bhatia R; Dhindsa M; Bhatia V
J Postgrad Med; 2004; 50(2):140-4. PubMed ID: 15235215
[TBL] [Abstract][Full Text] [Related]
3. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
[TBL] [Abstract][Full Text] [Related]
5. The treatment of polycystic ovary syndrome.
Ajossa S; Guerriero S; Paoletti AM; Orrù M; Melis GB
Minerva Ginecol; 2004 Feb; 56(1):15-26. PubMed ID: 14973407
[TBL] [Abstract][Full Text] [Related]
6. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
Svendsen PF; Nilas L; Nørgaard K; Madsbad S
Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
[TBL] [Abstract][Full Text] [Related]
7. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
Song J; Shen H; Li J; Huang Z; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
[TBL] [Abstract][Full Text] [Related]
8. Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
Diri H; Karaburgu S; Acmaz B; Unluhizarci K; Tanriverdi F; Karaca Z; Kelestimur F
Gynecol Endocrinol; 2016; 32(1):42-5. PubMed ID: 26370923
[TBL] [Abstract][Full Text] [Related]
9. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
Sharma ST; Nestler JE
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
11. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.
Katsiki N; Hatzitolios AI
Curr Opin Obstet Gynecol; 2010 Dec; 22(6):466-76. PubMed ID: 20724929
[TBL] [Abstract][Full Text] [Related]
12. Insulin sensitizers in polycystic ovary syndrome.
Pasquali R; Gambineri A
Front Horm Res; 2013; 40():83-102. PubMed ID: 24002407
[TBL] [Abstract][Full Text] [Related]
13. Metformin and glitazones: do they really help PCOS patients?
Pillai A; Bang H; Green C
J Fam Pract; 2007 Jun; 56(6):444-53. PubMed ID: 17543254
[TBL] [Abstract][Full Text] [Related]
14. Insulin-sensitizing agents in polycystic ovary syndrome.
Pasquali R; Gambineri A
Eur J Endocrinol; 2006 Jun; 154(6):763-75. PubMed ID: 16728533
[TBL] [Abstract][Full Text] [Related]
15. Thiazolinedione treatment in PCOS--an update.
Glintborg D; Andersen M
Gynecol Endocrinol; 2010 Nov; 26(11):791-803. PubMed ID: 20528570
[TBL] [Abstract][Full Text] [Related]
16. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
Franks S
Clin Endocrinol (Oxf); 2011 Feb; 74(2):148-51. PubMed ID: 21121941
[TBL] [Abstract][Full Text] [Related]
17. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
18. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
[TBL] [Abstract][Full Text] [Related]
19. Effect of metformin and spironolactone therapy on OGTT in patients with polycystic ovarian syndrome - a retrospective analysis.
Kulshreshtha B; Gupta N; Ganie MA; Ammini AC
Gynecol Endocrinol; 2012 Oct; 28(10):823-6. PubMed ID: 22475072
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, polycystic ovary syndrome and metformin.
Pugeat M; Ducluzeau PH
Drugs; 1999; 58 Suppl 1():41-6; discussion 75-82. PubMed ID: 10576524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
